I agree that this site is using cookies. You can find further informations here.
X
Johnson-Ansah, Hyacinthe
33  results:
Search for persons X
?
1

First-line second generation tyrosine kinase inhibitors in ..:

Balsat, Marie ; Alcazer, Vincent ; Etienne, Gabriel...
Leukemia Research.  130 (2023)  - p. 107308 , 2023
Link: https://doi.org/10.1016/..
 
?
2

ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and S..:

Baykal, Seda ; Voldoire, Maud ; Desterke, Christophe...
Turkish Journal of Hematology.  40 (2023)  2 - p. 101-117 , 2023
Link: https://doi.org/10.4274/..
 
?
3

Kinetics of early and late molecular recurrences after firs..:

Dulucq, Stéphanie ; Nicolini, Franck E. ; Rea, Delphine...
Haematologica.  107 (2022)  12 - p. 2859-2869 , 2022
Link: https://doi.org/10.3324/..
 
?
4

The Spliceosome: A New Therapeutic Target in Chronic Myeloi..:

Lebecque, Benjamin ; Bourgne, Celine ; Munje, Chinmay...
Cancers.  14 (2022)  19 - p. 4695 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Imatinib Optimized Therapy Improves Major Molecular Respons..:

Johnson-Ansah, Hyacinthe ; Maneglier, Benjamin ; Huguet, Françoise...
Pharmaceutics.  14 (2022)  8 - p. 1676 , 2022
Link: https://doi.org/10.3390/..
 
?
6

Long-term outcome of imatinib 400 mg compared to imatinib 6..:

Guilhot, Francois ; Rigal-Huguet, Françoise ; Guilhot, Joëlle...
Leukemia.  35 (2021)  8 - p. 2332-2345 , 2021
Link: https://doi.org/10.1038/..
 
?
7

Successful Imatinib therapy as a bridge to transplant in an..:

Hueso, Thomas ; Johnson-Ansah, Hyacinthe ; Decamp, Matthieu...
Current Research in Translational Medicine.  67 (2019)  4 - p. 149-151 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Aryl hydrocarbon receptor (AHR) is a novel druggable pathwa..:

Gentil, Melanie ; Hugues, Patricia ; Desterke, Christophe...
PLOS ONE.  13 (2018)  8 - p. e0200923 , 2018
Link: https://doi.org/10.1371/..
 
?
9

Imatinib Optimized Therapy Improves Major Molecular Respons..:

Johnson-Ansah, Hyacinthe ; Maneglier, Benjamin ; Huguet, Francoise...
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics14081676.  , 2022
Link: https://hal.science/hal-..
 
?
10

Imatinib Optimized Therapy Improves Major Molecular Respons..:

Johnson-Ansah, Hyacinthe ; Maneglier, Benjamin ; Huguet, Francoise...
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics14081676.  , 2022
Link: https://hal.science/hal-..
 
?
11

Imatinib Optimized Therapy Improves Major Molecular Respons..:

Johnson-Ansah, Hyacinthe ; Maneglier, Benjamin ; Huguet, Francoise...
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics14081676.  , 2022
Link: https://hal.science/hal-..
 
?
12

Imatinib Optimized Therapy Improves Major Molecular Respons..:

Johnson-Ansah, Hyacinthe ; Maneglier, Benjamin ; Huguet, Francoise...
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics14081676.  , 2022
Link: https://hal.science/hal-..
 
?
13

Imatinib Optimized Therapy Improves Major Molecular Respons..:

JOHNSON-ANSAH, Hyacinthe ; MANEGLIER, Benjamin ; HUGUET, Francoise...
1999-4923 (Print) 1999-4923 (Linking).  , 2022
Link: https://oskar-bordeaux.f..
 
?
14

Imatinib Optimized Therapy Improves Major Molecular Respons..:

Johnson-Ansah, Hyacinthe ; Maneglier, Benjamin ; Huguet, Francoise...
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics14081676.  , 2022
Link: https://hal.science/hal-..
 
?
15

Imatinib Optimized Therapy Improves Major Molecular Respons..:

Johnson-Ansah, Hyacinthe ; Maneglier, Benjamin ; Huguet, Francoise...
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics14081676.  , 2022
Link: https://hal.science/hal-..
 
1-15